Viant provides end-to-end solutions that support the world’s leading original equipment manufacturers with producing diagnostic, orthopedic, surgical and other medical products. Water Street invested in Viant (at the time, known as MedPlast) in 2016. Over the next two years, Water Street completed four strategic acquisitions that bolstered Viant’s clinical market expertise, global footprint, and portfolio of solutions. Today, Viant employs nearly 6,000 associates across 24 worldwide locations. The company is highly regarded for its deep materials expertise combined with its experience in engineering, manufacturing, assembly, packaging, and sterilization. Water Street is continuing to pursue additional acquisitions and organic investments that will build on Viant’s integrated portfolio of product solutions.
Chief Executive OfficerWork with us
Alton Shader leads the development and execution of Viant’s business strategy, spearheading the Company’s continuing expansion and driving accelerated growth, ensuring that Viant’s customers receive exceptional solutions and service. Joining Viant in 2019, Alton brings more than 20 years of global medical device leadership experience to the team and is highly regarded for driving growth across a range of companies. As President of Hill-Rom’s global Front Line Care business, which includes Welch Allyn, he established the company’s fastest-growing and most profitable global business. He achieved similar results when he led North America for Hill-Rom. Prior to joining Hill-Rom, Alton held senior positions in Europe for Baxter International before being promoted to General Manager of its U.S. Renal business. In his most recent role, Alton served as President and CEO Of Vein Clinics of America. Alton earned a bachelor’s degree in economics and psychology from Claremont McKenna College and an MBA from Stanford University.